EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

IgD‐Expressing Mature B Cells Exhibit Enhanced Sensitivity to Glucocorticoid‐Induced Cell Death

Kais Almohammad, Marc Young, Sabine Vettorazzi, Franziska Greulich, Mahmoud Alkhatib, Jan Tuckermann, Hassan Jumaa, Corinna S Setz

European Journal of Immunology · 2026

DOI: 10.1002/eji.70137 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Immunology, 2026. Verfasst von Kais Almohammad und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Immunology, Ulm University Medical Center, Albert-Einstein-Allee 11, Ulm, Germany. Hauptthemen laut MEDLINE: Immunoglobulin D, Glucocorticoids, Receptors, Glucocorticoid, B-Lymphocytes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CRC1279 : "Exploiting the Human Peptidome for Novel Antimicrobial and Anticancer Agents" to H.J., Further project funding by the DFG was granted to S.V. and F.G., J.T..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucocorticoids (GCs) regulate diverse physiological processes, comprising metabolism, immune responses, stress adaptation, and inflammation. Synthetic GCs are widely used for their powerful anti‐inflammatory and immunosuppressive effects, in the treatment of autoimmune diseases, allergies, and inflammation. Here, we investigated the role of the glucocorticoid receptor (GR) in B cell development and survival using both B cell‐specific GR‐deficient mice and continuous in vivo GR agonist treatments. Deletion of the GR in B cells altered splenic B cell subpopulations, increasing follicular and CD21 lo B cells and leading to the accumulation of IgM − /IgD − B cells. In vivo treatment with GR agonists, such as Dexamethasone (Dex) and Prednisolone (Pred), selectively depleted IgD hi follicular while enriching IgM hi marginal zone B cells. IgM hi B cells, which were more resistant to GC‐induced cell death, showed an increased expression of IL‐10 and genes involved in survival, suggesting a potential regulatory function. In vitro , B cell activation via CpG or lipopolysaccharide (LPS) altered IgM/IgD expression and B cell sensitivity to GR agonists, thereby leading to improved B cell survival and increased plasma cell differentiation. Together, these findings suggest that IgD downregulation and IgM upregulation are critical for B cell survival under GC exposure and that GR agonists promote the enrichment of IgM hi cells resistant to apoptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulin DGlucocorticoidsReceptors, GlucocorticoidB-LymphocytesAnimalsMiceImmunoglobulin MCell DifferentiationMice, KnockoutInterleukin-10DexamethasoneCell DeathLymphocyte ActivationCell SurvivalMice, Inbred C57BLPrednisoloneApoptosis

Stichwörter der Autor:innen

B cellsIgDIgMglucocorticoidsterminal differentiation

Substanzen

Immunoglobulin DGlucocorticoidsReceptors, GlucocorticoidImmunoglobulin MInterleukin-10DexamethasonePrednisolone

Autor:innen und Institutionen

  • Institute of Immunology, Ulm University Medical Center, Albert-Einstein-Allee 11, Ulm, Germany.
  • Department of Cardiology, University Heart Center Ulm, Albert-Einstein-Allee 23, Ulm, Germany.
  • Institute of Comparative Molecular Endocrinology and Physiology, Ulm University, Helmholtzstr. 8/1, Ulm, Germany.
  • Chair of Metabolic Programming, TUM School of Life Sciences, ZIEL-Institute For Food & Health, Technische Universität München, Gregor-Mendel-Str. 2, Freising, Germany.
  • Department of Neurology, Ulm University Medical Center, Oberer Eselsberg 45, Ulm, Germany.
  • German Center for Child and Adolescent Health (DZKJ), partner site Ulm, Frauensteige 14a, Ulm, Germany.

Förderung

  • CRC1279 : "Exploiting the Human Peptidome for Novel Antimicrobial and Anticancer Agents" to H.J.
  • Further project funding by the DFG was granted to S.V. and F.G.
  • J.T.
  • S.V.
  • H.J.
  • SFB1506: "Aging at Interfaces" to H.J. and J.T.

Zitieren

APA

Almohammad, K., Young, M., Vettorazzi, S., Greulich, F., Alkhatib, M., Tuckermann, J., Jumaa, H., & Setz, C. S. (2026). IgD‐Expressing Mature B Cells Exhibit Enhanced Sensitivity to Glucocorticoid‐Induced Cell Death. European Journal of Immunology. https://doi.org/10.1002/eji.70137

Vancouver

Almohammad K, Young M, Vettorazzi S, Greulich F, Alkhatib M, Tuckermann J, et al. IgD‐Expressing Mature B Cells Exhibit Enhanced Sensitivity to Glucocorticoid‐Induced Cell Death. European Journal of Immunology. 2026. doi:10.1002/eji.70137

BibTeX
@article{Almohammad2026,
  author = {Almohammad, Kais and Young, Marc and Vettorazzi, Sabine and Greulich, Franziska and Alkhatib, Mahmoud and Tuckermann, Jan and Jumaa, Hassan and Setz, Corinna S},
  title = {IgD‐Expressing Mature B Cells Exhibit Enhanced Sensitivity to Glucocorticoid‐Induced Cell Death},
  journal = {European Journal of Immunology},
  year = {2026},
  doi = {10.1002/eji.70137}
}
Kostenlos starten →